United Therapeutics Corporation (Nasdaq: UTHR) announced the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial hypertension (PAH). Preliminary analysis demonstrates that the trial did not achieve statistical significance for the primary endpoint, six minute walk (6MW) distance at Week 16.
The FREEDOM-C trial was a randomized,

Children who become very upset when their parents fight are more likely to develop psychological problems. But little is known about what happens beyond these behavioral reactions in terms of children’s biological responses. A new study has found that children who are very distressed when their parents fight also have higher levels of cortisol, a […]

Racial disparity in the control of hypertension contributes to the deaths of almost 8,000 black men and women in the United States annually, according to a first-of-its-kind study published today in the Annals of Family Medicine by University of Rochester Medical Center researchers.
The researchers concluded that the deaths could be avoided or postponed if blacks […]

The Maine Youth Suicide Prevention Program (MYSPP) recently learned that it has been selected to receive a $500,000 grant to enhance its efforts in high schools across the state.
generic propecia online buy The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded

So advise researchers from several European countries following a huge international study. A major international study shows that the frequency of non-infectious rhinitis in children varies considerably
among regions of the world. The project, which monitored some 54,000 children from 22 countries, also shows that only a small proportion of such rhinitis cases are caused by […]

People suffering from anxiety and depression prefer to receive counselling over medication because they feel it addresses their underlying problems and not just their symptoms.
This is one of the key findings in a review of UK and international research studies into the clinical-effectiveness, cost-effectiveness and acceptability

Men’s Health News
Scientists have discovered that 1 in 7 men have a genetic risk for baldness. Researchers at Canada’s McGill University and King’s College London along with scientists at drug company GlaxoSmithKline have solved the mystery of male pattern baldness but say treating it will require more research.
The scientists have identified two genetic variants in […]

An early
proof-of-concept study presented shows promising results for imatinib
mesylate in the treatment of pulmonary arterial hypertension (PAH), a
severe, incurable blood vessel disorder.
Preliminary findings from a 59-patient, multi-center Phase II clinical
trial suggest imatinib mesylate provides a treatment benefit, as
demonstrated by a significant